A double-blind, randomized, single centre, two-arm, placebo-controlled, comparative clinical study to evaluate the safety, in-use tolerability and efficacy of Moisturizing Cream in female subjects with varied skin type. - NI

DPKA Universal Consumer Ventures Private Limited0 个研究点目标入组 96 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1) Subjects with dry / normal / oily / sensitive skin.
•oSubjects with self-perceived normal skin.
•oSubjects with dry (readings between 30 – 40) as assessed by MoistureMeterSC.
•oSubjects with oily skin having Sebumeter measurement > 150 (µg/cm2).
•oSubjects with sensitive skin based on Dr. Baumann’s skin type questionnaire.
•2) Subjects having good general health as determined by the Investigator on the basis of medical history.
•3) Females of Childbearing potential must have a negative urine pregnancy test performed during Visit 01.

•1) Subjects undergoing treatment for skin lightening or subjects using other marketed skin lightening products during the study period or in the past 6 weeks.
•2) Subjects who are receiving topical or systemic treatments.
•3) Subjects receiving medications (e.g., steroids or antihistamines) would compromise the study.
•4) Chronic illness which may influence the cutaneous state.
•5) Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments.

发起方

DPKA Universal Consumer Ventures Private Limited